IP Library Granted Patent US 11,230,722
Granted Patent B2
US 11,230,722 · App. 15/914,676 · Granted Jan 25, 2022

Nutritional supplements and therapeutic compositions comprising (r)-3-hydroxybutyrate derivatives

Inventors: Richard Lewis Veech (Rockville, MD); Michael Todd King (Gaithersburg, MD); Kieran Clarke (Oxford, GB)
Assignees: Oxford University Innovation Limited; U.S. Dept. Of Health and Human Services, (DHHS), U.S. Government
C12P7/625C07C51/09C07C69/675C07H13/04C08G63/06C12P7/26C12P7/62Y02P20/54
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,230,722
App. No.
15/914,676
Granted
Jan 25, 2022
Kind
B2
Abstract

Novel compounds and compositions containing (R)-3-hydroxybutyrate derivatives are disclosed. The compounds and compositions can be used as nutritional supplements to increase physical performance and as therapeutics to ameliorate symptoms of medical conditions, particularly neurological conditions, such as Alzheimer's and similar conditions. Novel methods for making R-3-hydroxybutyrate derivatives also are disclosed. Exemplary methods employ a supercritical solvent, such as supercritical carbon dioxide, and employ a lipase catalyzed esterification or transesterification reaction to produce the (R)-3-hydroxybutyrate derivatives.

Claims (11)

1. A compound of Formula 3:

or a pharmaceutically acceptable salt thereof, wherein:

R is (R)-1,3-butanediol;

m is 1;

n is 1; and

x is 2.

2. A pharmaceutical composition comprising a compound of claim 1 and a pharmaceutically acceptable carrier.

3. The compound of claim 1 , wherein: m is 1.

4. A pharmaceutical composition comprising the compound of claim 3 and a pharmaceutically acceptable carrier.

5. The pharmaceutical composition of claim 2 , formulated for oral administration as a nutritional or dietary supplement.

6. The pharmaceutical composition of claim 4 , formulated for oral administration as a nutritional or dietary supplement.

Continuity (4)
Continuation 10559258
Provisional Application 60529873 · Dec 15, 2003
Provisional Application 60475848 · Jun 3, 2003
Related Publication 20180195096A1 · Jul 12, 2018
Cited By (2)
US 12,226,387 US 12,377,032